Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding
Pharmacy Times
JULY 18, 2025
The definition of "essentially a copy" is pivotal, influencing compounding practices and legal interpretations. All of this is in the face of yet another round of manufacturer cease-and-desist letters to compounding pharmacies and even physician offices demanding they cease all compounding, dispensing, and sale of compounded GLP-1s.
Let's personalize your content